Abstract
Stress-hyperglycemia and insulin resistance are exceedingly common in critically ill patients, particularly those with sepsis. Multiple pathogenetic mechanisms are responsible for this metabolic syndrome; however, increased release of pro-inflammatory mediators and counter-regulatory hormones may play a pivotal role. Recent data suggests that hyperglycemia may potentiate the pro-inflammatory response while insulin has the opposite effect. Furthermore, emerging evidence suggests that tight glycemic control will improve the outcome of critically ill patients. This paper reviews the pathophysiology of stress hyperglycemia in the critically ill septic patient and outlines a treatment strategy for the management of this disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the nited States from 1979 through 2000. N Engl J Med 348:1546–1554
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 29:1303–1310
Friedman G, Silva E, Vincent JL (1998) Has the mortality of septic shock changed with time? Crit Care Med 26:2078–2086
Marik PE, Varon J (2001) Sepsis: state of the art. Dis Mon 47:463–532
Bone RC (1996) Sir Isaac Newton, sepsis, SIRS and CARS. Crit Care Med 24:1125–1128
Bone RC, Sibbald WJ, Sprung CL (1992) The ACCP-SCCM Consensus Conference on sepsis and organ failure. Chest 101:1481–1483
Bone RC, Grodzin CJ, Balk RA (1997) Sepsis: a new hypothesis for patho- genesis of the disease process. Chest 112:235–243
Natanson C, Esposito CJ, Banks SM (1998) The sirens' songs of confirmatory sepsis trials: selection bias and sampling error. Crit Care Med 26:1927–1931
Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gerstenberger EP, Fitz Y, Danner RL, Natanson C (2002) Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166:1197–1205
Dellinger RP (1999) Severe sepsis trials: Why have they failed? Minerva Anestesiol 65:340–345
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367
van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus gly- cemic control. Crit Care Med 31:359366
Marik PE, Zaloga GP (2002) Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 122:1784–1796
Hart BB, Stanford GG, Ziegler MG, Lake CR, Chernow B (1989) Cate- cholamines: study of interspecies variation. Crit Care Med 17:12031218
van den Berghe G (2002) Neuroendocrine pathobiology of chronic illness. Crit Care Clin 18:509–528
Siegel JH, Cerra FB, Coleman B, Giovannini I, Shetye M, Border JR, McMenamy RH (1979) Physiological and metabolic correlations in human sepsis. Invited commentary. Surgery 86:163–193
Clowes GH, Martin H, Walji S, Hirsch E, Gazitua R, Goodfellow R (1978) Blood insulin responses to blood glucose levels in high output sepsis and spetic shock. Am J Surg 135:577–583
Dahn MS, Jacobs LA, Smith S, Hans B, Lange MP, Mitchell RA, Kirkpatrick JR (1985) The relationship of insulin production to glucose metabolism in severe sepsis. Arch Surg 120:166–172
Mizock BA (2001) Alterations in fuel metabolism in critical illness hyper- glycemia. Best Pract Res Clin En- docrinol Metab 15:533–551
Mehta VK, Hao W, Brooks-Worrell BM, Palmer JP (1994) Low-dose in- terleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 130:208–214
Shepard PR, Kahn BB (1999) Glucose transporters and insulin action. Implications for insulin resistance and diabetes mellitus. N Engl J Med 341:248257
Pessin JE, Saltiel AR (2000) Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106:165–169
McCowen KC, Malhotra A, Bistrian BR (2001) Stress-induced hyperglycemia. Crit Care Clin 17:107–124
Frankenfield DC, Omert LA, Badellino MM, Wiles CE, III, Bagley SM, Goodarzi S, Siegel JH (1994) Correlation between measured energy expenditure and clinically obtained variables in trauma and sepsis patients. J Parenter Enteral Nutr 18:398–403
Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL (2000) Insulin resistance and substrate utilization in human endotoxemia. J Clin En- docrinol Metab 85:3770–3778
Gelb AW, Bayona NA, Wilson JX, Cechetto DF (2002) Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiol 96:1183–1190
Sakurai Y, Zhang XJ, Wolfe RR (1996) TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. Am J Physiol 270:E864-E872
Lang CH, Dobrescu C (1991) Gramnegative infection increases noninsulin-mediated glucose disposal. Endocrinology 128:645–653
Meszaros K, Lang CH, Bagby GJ, Spitzer JJ (1987) Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Bio- chem Biophys Res Commun 149:1–6
Bird TA, Davies A, Baldwin SA, Saklatvala J (1990) Interleukin 1 stimulates hexose transport in fibro- blasts by increasing the expression of glucose transporters. J Biol Chem 265:13578–13583
Green CJ, Campbell IT, O'Sullivan E, Underhill S, McLaren DP, Hipkin LJ, MacDonald IA, Russell J (1995) Septic patients in multiple organ failure can oxidize infused glucose, but non- oxidative disposal (storage) is impaired. Clin Sci 89:601–609
Saeed M, Carlson GL, Little RA, Irving MH (1999) Selective impairment of glucose storage in human sepsis. Br J Surg 86:813–821
Mizock BA (1997) Alterations in fuel metabolism in critical illness. Hyper- glycemia. In: Ober KP (ed) Endocrinology of critical disease. Humana Press, Totawa, New Jersey, pp 197297
Mesotten D, Delhanty PJ, Vanderhoy- donc F, Hardman KV, Weekers F, Baxter RC, Van den BG (2002) Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Me- tab 87:5516–5523
Jeevanandam M, Young DH, Schiller WR (1990) Glucose turnover, oxidation, and indices of recycling in severely traumatized patients. J Trauma 30:582–589
Cerra FB (1987) Hypermetabolism, organ failure, and metabolic support. Surgery 101:1–14
Wolfe RR (1997) Substrate utilization/ insulin resistance in sepsis/trauma. Baillieres Clin Endocrinol Metab 11:645–657
Petit F, Bagby GJ, Lang CH (1995) Tumor necrosis factor mediates zy- mosan-induced increase in glucose flux and insulin resistance. Am J Physiol 268:E219-E228
Roh MS, Moldawer LL, Ekman LG, Dinarello CA, Bistrian BR, Jeevanandam M, Brennan MF (1986) Stimulatory effect of interleukin-1 upon hepatic metabolism. Metabolism 35:419–424
Lang CH (1992) Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism. Am J Physiol 263:E703-E711
Chambrier C, Laville M, Rhzioual BK, Odeon M, Bouletreau P, Beylot M (2000) Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci 99:321–328
Aljada A, Ghanim H, Assian E, Dandona P (2002) Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 51:487–491
Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665668
Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A (1995) Tumor necrosis factor alpha-induced phos- phorylation of insulin receptor sub- strate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270:23780–23784
Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, Zick Y (1997) A molecular basis for insulin resistance. Elevated serine/threonine phos- phorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamem- brane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphoryla- tion. J Biol Chem 272:29911–29918
Nunes AL, Carvalheira JB, Carvalho CR, Brenelli SL, Saad MJ (2001) Tissue-specific regulation of early steps in insulin action in septic rats. Life Sci 69:2103–2112
Hotamisligil GS, Budavari A, Murray D, Spiegelman BM (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94:1543–9
Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM (1994) Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854–4858
Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J (2002) Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277:48115–48121
Gay NJ, Keith FJ (1991) Drosophila Toll and IL-1 receptor. Nature 351:355–356
Belvin MP, Anderson KV (1996) A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Develop Biol 12:393–416
Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: Tolllike receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccha- ride: evidence for TLR4 as the Lps gene product. J Immunol 162:37493752
Barnes PJ, Karin M (1997) Nuclear factor-kB-A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066–1071
Chiasson JL, Shikama H, Chu DT, Exton JH (1981) Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J Clin Invest 68:706–713
Haring H, Kirsch D, Obermaier B, Ermel B, Machicao F (1986) Decreased tyrosine kinase activity of insulin receptor isolated from rat adi- pocytes rendered insulin-resistant by catecholamine treatment in vitro. Biochem J 234:59–66
Dimitriadis G, Leighton B, Parry- Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, ANewsholme EA (1997) Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 321:707–712
Smith TR, Elmendorf JS, David TS, Turinsky J (1997) Growth hormone- induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. Am J Physiol 272:E1071- E1079
Dominici FP, Cifone D, Bartke A, Turyn D (1999) Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH- transgenic mice. Am J Physiol 277:E447-E454
Khaodhiar L, McCowen K, Bistrian B (1999) Perioperative hyperglycemia, infection or risk? Curr Opin Clin Nutr Metab Care 2:79–82
Norhammar AM, Ryden L, Malmberg K (1999) Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 22:1827–1831
Zindrou D, Taylor KM, Bagger JP (2001) Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care 24:1634–1639
Malmberg K, Norhammar A, Wedel H, Ryden L (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long- term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–26232
Malmberg K (1997) Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br Med J 314:15121515
Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L (1995) Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26:57–65
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:24262432
Woo J, Lam CW, Kay R, Wong AH, Teoh R, Nicholls MG (1990) The influence of hyperglycemia and diabetes mellitus on immediate and 3- month morbidity and mortality after acute stroke. Arch Neurol 47:11741177
Dandona P, Aljada A, Bandyopadhyay A (2003) The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia. Diabetes Care 26:516–519
Hansen TK, Thiel S, Wouters PJ, Christiansen JS, van den Berghe G (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082–1088
Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P (2000) Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85:2970–2973
Straczkowski M, Dzienis- Straczkowska S, Stepien A, Kowalska I, Szelachowska M, Kinalska I (2002) Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 87:4602–4606
Chettab K, Zibara K, Belaiba SR, McGregor JL (2002) Acute hypergly- caemia induces changes in the transcription levels of 4 major genes in human endothelial cells: macroarrays- based expression analysis. Thromb Haemost 87:141–148
Standiford TJ, Kunkel SL, Green- berger MJ, Laichalk LL, Strieter RM (1996) Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol 59:24–28
Hack CE, Aarden LA, Thijs LG (1997) Role of cytokines in sepsis. Adv Immunol 66:101–195
Multz AS, Cohen R (2003) Systemic response to pneumonia in the critically ill patient. Semin Resp Infect 18:6871
Aljada A, Ghanim H, Mohanty P, Hofmeyer D, Tripathy D, Dandona P (2002) Glucose activates nuclear factor kappa B pathway in mononuclear cells (MNC) and induces an increase in p47phox. subunit in MNC membranes [Abstract]. Diabetes 51 (Suppl 2):A537
Yorek MA, Dunlap JA (2002) Effect of increased concentration of D-glu- cose or L-fucose on monocyte adhesion to endothelial cell monolayers and activation of nuclear factor-kap- paB. Metabolism 51:225–234
Guha M, Bai W, Nadler JL, Natarajan R (2000) Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hy- perglycemia-induced oxidant stress- dependent and -independent pathways. J Biol Chem 275:17728–17739
Ceriello A, Bortolotti N, Motz E, Pieri C, Marra M, Tonutti L, Lizzio S, Feletto F, Catone B, Taboga C (1999) Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyper- glycemia. Metabolism 48:1503–1508
Ceriello A (1993) Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36:1119–1125
Aljada A, Ghanim H, Mohanty P, Syed T, Dandona P (2003) Glucose intake induces an increase in AP-1 and Egr-1 in mononuclear cells and plasma matrix metalloproteinases and tissue factor (TF) concentrations. J Clin En- docrinol Metab
Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F (1997) Vascular effects of acute hy- perglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hy- perglycemia. Circulation 95:17831790
Pozzilli P, Leslie RD (1994) Infections and diabetes: mechanisms and prospects for prevention. Diabet Med 11:935–941
Mowlavi A, Andrews K, Milner S, Herndon DN, Heggers JP (2000) The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg 45:629–632
Furnary AP, Zerr KJ, Grunkemeier GL, Starr A (1999) Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67:352–360
Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A (1997) Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63:356–361
McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN (2001) Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol 70:395–404
Evans TW (2001) Hemodynamic and metabolic therapy in critically ill patients. N Engl J Med 345:1417–1418
Rassias AJ, Marrin CA, Arruda J, Whalen PK, Beach M, Yeager MP (1999) Insulin infusion improves neu- trophil function in diabetic cardiac surgery patients. Anesth Analg 88:1011–1016
Nielson CP, Hindson DA (1989) Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 38:1031–1035
Kwoun MO, Ling PR, Lydon E, Im- rich A, Qu Z, Palombo J, Bistrian BR (1997) Immunologic effects of acute hyperglycemia in nondiabetic rats. J Parenter Enteral Nutr 21:91–95
Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S (2001) Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86:3257–3265
Aljada A, Ghanim H, Mohanty P, Kapur N, Dandona P (2002) Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mono- nuclear cells (MNC) and reduces plasma tissue factor (TF) and plasmi- nogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Me- tab 87:1419–1422
Aljada A, Dandona P (2000) Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 49:147–150
Peng HB, Spiecker M, Liao JK (1998) Inducible nitric oxide: an autoregula- tory feedback inhibitor of vascular inflammation. J Immunol 161:19701976
Spiecker M, Darius H, Kaboth K, Hubner F, Liao JK (1998) Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 63:732–739
Spiecker M, Peng HB, Liao JK (1997) Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 272:30969–30974
Meldrum DR, McIntyre RC, Sheridan BC, Cleveland JC Jr, Fullerton DA, Harken AH (1997) L-arginine decreases alveolar macrophage proin- flammatory monokine production during acute lung injury by a nitric oxide synthase-dependent mechanism. J Trauma 43:888–893
Laroux FS, Lefer DJ, Kawachi S, Scalia R, Cockrell AS, Gray L, van der Heyde H, Hoffman JM, Grisham MB (2000) Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxidants Redox Signaling 2:391–396
Torre A de la, Schroeder RA, Punzalan C, Kuo PC (1999) Endotoxin-mediat- ed S-nitrosylation of p50 alters NF- kappa B-dependent gene transcription in ANA-1 murine macrophages. J Immunol 162:4101–4108
Walley KR, McDonald TE, Hi- gashimoto Y, Hayashi S (1999) Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury. Am J Respir Crit Care Med 160:698–704
Pahl HL (1999) Activators and target genes of rel/NF-kappaB transcription factors. Oncogene 18:6853–6866
Bohrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D, Bottiger BW, Stern DM, Waldherr R, Saeger HD, Ziegler R, Bierhaus A, Martin E, Nawroth PP (1997) Role of NFkappaB in the mortality of sepsis. J Clin Invest 100:972–985
Arnalich F, Garcia-Palomero E, Lopez J, Jimenez M, Madero R, Renart J, Vazquez JJ, Montiel C (2000) Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immunol 68:1942–1945
Paterson RL, Galley HF, Dhillon JK, Webster NR (2000) Increased nuclear factor kappa B activation in critically ill patients who die. Crit Care Med 28:1047–1051
Marik PE (2002) Nuclear factor-kap- paB inhibition in sepsis: steroids versus specific nuclear factor-kappaB inhibitors? Crit Care Med 30:2393–2394
Christman JW, Lancaster LH, Blackwell TS (1998) Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 24:1131–1138
Fink MP (2003) Nulcear factor-kB: Is it a therapeutic target for the adjuvant treatment of sepsis. Crit Care Med 31:2400–2402
Liu SF, Ye X, Malik AB (1999) Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation 100:1330–1337
Marik PE, Zaloga G (2003) Gastric vs post-pyloric feeding? A systematic review. Intensive Care Med
Marik PE, Zaloga GP (2001) Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med 29:2264–2270
Marik PE, Pinsky MR (2003) Death by total parenteral nutrition. Intensive Care Med 29:867–869
Ghanim H, Garg R, Aljada A, Mohanty P, Kumbkarni Y, Assian E, Hamouda W, Dandona P (2001) Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential an- tiatherosclerotic effect in the obese. J Clin Endocrinol Metab 86:13061312
Aljada A, Garg R, Ghanim H, Mohanty P, Hamouda W, Assian E, Dandona P (2001) Nuclear factor- kappaB suppressive and inhibitor- kappaB stimulatory effects of trogli- tazone in obese patients with type 2 diabetes: evidence of an antiinflam- matory action? J Clin Endocrinol Metab 86:3250–3256
Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH (2001) In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 104:2588–2594
Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatteijee PK, Thiemer- mann C (2002) Ligands of the perox- isome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 16:1027–1040
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Marik, P.E., Raghavan, M. (2012). Stress-hyperglycemia, insulin and immunomodulation in sepsis. In: Pinsky, M.R., Brochard, L., Mancebo, J., Antonelli, M. (eds) Applied Physiology in Intensive Care Medicine 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28233-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-28233-1_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28232-4
Online ISBN: 978-3-642-28233-1
eBook Packages: MedicineMedicine (R0)